Skip to main content
Top
Published in:

Open Access 01-07-2025 | Granulomatosis with Polyangiitis | Case Based Review

Pulmonary arteritis in the course of granulomatosis with polyangiitis

Authors: Sobuń Aleksandra, Madej Marta, Mroczek Ewa, Guziński Maciej, Wiland Piotr, Sebastian Agata

Published in: Rheumatology International | Issue 7/2025

Login to get access

Abstract

Granulomatosis with polyangiitis (GPA) is a rare disease that belongs to the group of necrotizing systemic vasculitis, which is characterized by the involvement of small and medium-sized blood vessels, the formation of granulomas, and the presence of proteinase 3-anti-neutrophil cytoplasmic antibodies (PR3-ANCA). The disease typically involves the upper and lower respiratory tract and kidneys, but other organs and systems may also be involved. A rare manifestation of the disease is the involvement of large vessels, which may occur in the form of aneurysms, dissection and stenosis. We present the case of a 39-year-old male patient who was diagnosed with GPA several years ago, with the involvement of lungs, kidneys, skin and inflammation of the ascending aorta. The patient currently reported fever, cough and dyspnea. The imaging studies showed stenosis of the right and left pulmonary arteries. The treatment included glucocorticosteroids and rituximab. A review of the literature on pulmonary artery involvement in granulomatosis with polyangiitis was performed, seven case reports meeting such criteria were found.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Pulmonary arteritis in the course of granulomatosis with polyangiitis
Authors
Sobuń Aleksandra
Madej Marta
Mroczek Ewa
Guziński Maciej
Wiland Piotr
Sebastian Agata
Publication date
01-07-2025
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 7/2025
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-025-05896-2

Keynote webinar | Spotlight on advances in lupus

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Learn more about novel biomarkers for diagnosis and monitoring, and familiarize yourself with current and emerging targeted therapies.

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Watch now

EULAR 2025

Explore the latest news and updates from the annual congress of the European Alliance of Associations for Rheumatology.

Read more